Integrated analysis of bulk and single-cell RNA sequencing reveals the impact of nicotinamide and tryptophan metabolism on glioma prognosis and immunotherapy sensitivity.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: TCGA/CGGA datasets provide discovery and validation cohorts; glioma cell migration/invasion assays and pathway analyses support selected genes.
Technology: Bulk/single-cell expression analyses and LASSO survival modeling identify nicotinamide/tryptophan-related glioma risk groups; TGFBI perturbation experiments test a proposed tumor-cell mechanism.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Bulk/single-cell expression analyses and LASSO survival modeling identify nicotinamide/tryptophan-related glioma risk groups; TGFBI perturbation experiments test a proposed tumor-cell mechanism.
- Limitation / still unknown
- Computational cohorts and cell assays support a candidate mechanism, not clinical immunotherapy response.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC11514892/unicode
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.